Department of Pediatrics, Vanderbilt University, Nashville, Tennessee 37232, USA.
J Clin Endocrinol Metab. 2011 Nov;96(11):E1782-8. doi: 10.1210/jc.2011-1577. Epub 2011 Aug 24.
The metabolic syndrome (MetS) is associated with increased risk of diabetes and cardiovascular disease (CVD). Numerous groups have shown increased circulating biomarkers of inflammation in MetS. However, there are scanty data on the cellular sources contributing to this low-grade inflammation.
The aim of this study was to determine the role of sc adipose tissue (SAT) biology in nascent MetS without concomitant diabetes or CVD.
Subjects with MetS and controls were recruited after informed consent. Fasting blood was collected, and SAT was obtained by biopsy.
Circulating biomarkers of inflammation and insulin resistance, high-sensitivity C-reactive protein (hsCRP), IL-6, IL-1β, leptin, serum amyloid A, and retinol-binding protein-4 (RBP-4) concentrations were significantly higher in the MetS subjects than controls, whereas adiponectin concentrations were lower. In SAT, leptin, RBP-4, CRP, serum amyloid A, plasminogen activator inhibitor-1, IL-1, IL-6, IL-8, and monocyte chemotactic protein-1 (MCP-1) levels were significantly higher in MetS than controls. These differences except for RBP-4 persisted after adjusting for waist circumference. In addition, there were significantly increased numbers of macrophages infiltrating the SAT of MetS and increased numbers of crown-like structures compared with controls. hsCRP correlated positively with homeostasis model assessment and SAT MCP-1 and negatively with adiponectin. Homeostasis model assessment correlated positively with plasminogen activator inhibitor-1, RBP-4, and SAT MCP-1.
We make the novel observation that SAT of MetS has increased macrophage recruitment with cardinal crown-like structure features and contributes to the increased cellular inflammation that produces increased levels of biomarkers that are correlated with both insulin resistance and low-grade inflammation. These aberrations could contribute to the progression of MetS and the increased risk for diabetes and CVD.
代谢综合征(MetS)与糖尿病和心血管疾病(CVD)风险增加相关。许多研究小组已经发现 MetS 患者循环炎症生物标志物增加。然而,关于导致这种低度炎症的细胞来源的数据很少。
本研究旨在确定在没有合并糖尿病或 CVD 的情况下,新生 MetS 中内脏脂肪组织(SAT)生物学的作用。
在获得知情同意后,招募了 MetS 患者和对照组。采集空腹血,并通过活检获得 SAT。
MetS 患者的循环炎症和胰岛素抵抗生物标志物、高敏 C 反应蛋白(hsCRP)、IL-6、IL-1β、瘦素、血清淀粉样蛋白 A 和视黄醇结合蛋白-4(RBP-4)浓度明显高于对照组,而脂联素浓度较低。在 SAT 中,瘦素、RBP-4、CRP、血清淀粉样蛋白 A、纤溶酶原激活物抑制剂-1、IL-1、IL-6、IL-8 和单核细胞趋化蛋白-1(MCP-1)水平在 MetS 中明显高于对照组。除了 RBP-4 之外,这些差异在调整腰围后仍然存在。此外,与对照组相比,MetS 的 SAT 中有更多的巨噬细胞浸润,并有更多的冠层样结构。hsCRP 与稳态模型评估呈正相关,与 SAT MCP-1 呈负相关。稳态模型评估与纤溶酶原激活物抑制剂-1、RBP-4 和 SAT MCP-1 呈正相关。
我们观察到一个新的现象,即 MetS 的 SAT 有更多的巨噬细胞募集,具有主要的冠层样结构特征,并导致细胞炎症增加,产生与胰岛素抵抗和低度炎症相关的生物标志物水平增加。这些异常可能导致 MetS 进展和糖尿病和 CVD 风险增加。